Scenery of Staphylococcus implant infections in orthopedics

Future Microbiology

Volumn 6, Issue 11, 2011, Pages 1329-1349

  Montanaro, Lucio ^a,b   Speziale, Pietro ^c   Campoccia, Davide ^a   Ravaioli, Stefano ^a,b   Cangini, Ilaria ^a,b   Pietrocola, Giampiero ^c   Giannini, Sandro ^a   Arciola, Carla Renata ^a,b  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Adhesins; Antibiotic loaded biomaterials; Biofilm; DNA vaccines; Implant infections; Infection resistant materials; MSCRAMMs; Orthopedic implants; Peptide nucleicacids; Staphylococcus aureus; Staphylococcus epidermidis; Vaccines

Indexed keywords

ADHESIN; ANTIBIOTIC AGENT; BIOMATERIAL; DNA VACCINE; PEPTIDE NUCLEIC ACID; STAPHYLOCOCCUS VACCINE;

BACTERIAL STRAIN; BACTERIUM ADHERENCE; BIOFILM; CELL SURFACE; DEVICE INFECTION; GENE SILENCING; HIP ARTHROPLASTY; HUMAN; INCIDENCE; KNEE ARTHROPLASTY; MASTITIS; MATERIAL COATING; NONHUMAN; ORTHOPEDIC EQUIPMENT; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

ADHESINS, BACTERIAL; BACTERIAL ADHESION; BIOFILMS; HUMANS; ORTHOPEDIC PROCEDURES; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 81255157135     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.117     Document Type: Review

References (173)

1. Serra-Sutton V, Allepuz A, Espallargues M, Labek G, Pons JM. Arthroplasty registers: a review of international experiences. Int. J. Technol. Assess Health Care 25, 63-72 (2009).
2. Kurtz S, Ong K, Lau E et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone. Joint. Surg. Am. 89, 780-785 (2007). (Pubitemid 46564282)
3. An YH, Friedman RJ. Concise review of mechanisms of bacterial adhesion to biomaterial surfaces. J. Biomed. Mater. Res. 43, 338-348 (1998). (Pubitemid 28390337)
4. Campoccia D, Montanaro L, Arciola CR. The significance of infection related to orthopedic devices and issues of antibiotic resistance Biomaterials 27, 2331-2339 (2006). (Pubitemid 41821812)
5. Zimmerli W, Waldvogel FA, Vaudaux P et al. Pathogenesis of foreign body infection: description and characteristics of an animal model. J. Infect. Dis. 146, 487-497 (1982). (Pubitemid 12004448)
6. Murdoch DR, Roberts SA, Fowler VG Jr et al. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin. Infect. Dis. 32, 647-649 (2001). (Pubitemid 32565009)
7. Lalani T, Chu VH, Grussemeyer CA et al. Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections. Scand. J. Infect. Dis. 40(11-12), 973-977 (2008).
8. Sendi P, Banderet F, Graber P et al. Periprosthetic joint infection following Staphylococcus aureus bacteremia. J. Infect. 63(1), 17-22 (2011).
9. Sculco TP. The economic impact of infected total joint arthroplasty. Instr. Course Lect. 42, 349-351 (1993).
10. Katz JN, Losina E, Barrett J et al. Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States Medicare population. J. Bone Joint Surg. Am. 83, 1622-1629 (2001).
11. Mahomed NN, Barrett J, Katz JN et al. Epidemiology of total knee replacement in the United States Medicare population. J. Bone Joint Surg. Am. 87, 1222-1228 (2005). (Pubitemid 40756622)
12. Jmsen E, Furnes O, Engesaeter LB et al. Prevention of deep infection in joint replacement surgery. Acta Orthop. 81, 660-666 (2010).
13. Phillips JE, Crane TP, Noy M et al. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J. Bone Joint Surg. Br. 88, 943-948 (2006). (Pubitemid 44057185)
14. Pulido L, Ghanem E, Joshi A et al. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin. Orthop. Relat. Res. 466, 1710-1715 (2008).
15. Jmsen E, Varonen M, Huhtala H et al. Incidence of prosthetic joint infections after primary knee arthroplasty. J. Arthroplasty 25, 87-92 (2010).
16. Jmsen E, Huotari K, Huhtala H et al. Low rate of infected knee replacements in a nationwide series-is it an underestimate?. Acta Orthop. 80, 205-212 (2009).
17. Huotari K, Lyytikinen O, Ollgren JV et al. Hospital Infection Surveillance Team. Disease burden of prosthetic joint infections after hip and knee joint replacement in Finland during 1999-2004: capturerecapture estimation. J. Hosp. Infect. 75, 205-208 (2010).
18. Leone JM, Hanssen AD. Management of infection at the site of a total knee arthroplasty. Instr. Course Lect. 55, 449-461 (2006).
19. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N. Engl. J. Med. 351, 1645-1654 (2004).
20. Tsukayama DT, Goldberg VM, Kyle R. Diagnosis and management of infection after total knee arthroplasty. J. Bone Joint Surg. Am. 85-A (Suppl. 1), S75-S80 (2003).
21. Arciola CR, An YH, Campoccia D et al. Etiology of implant orthopedic infections: a survey on 1027 clinical isolates. Int. J. Artif. Organs. 28, 1091-1100 (2005). (Pubitemid 43085402)
22. Boles BR, Horswill AR. Staphylococcal biofilm disassembly. Trends Microbiol. 19(9), 449-455 (2011).
23. von Eiff C, Arciola CR, Montanaro L et al. Emerging Staphylococcus species as new pathogens in implant infections. Int. J. Artif. Organs. 29, 360-367 (2006). (Pubitemid 43931863)
24. Jarraud S, Mougel C, Thioulouse J et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect. Immun. 70, 631-641 (2002). (Pubitemid 34083822)
25. Otto M. A MRSA-terious enemy among us: end of the PVL controversy?. Nat. Med. 17, 169-170 (2011).
26. Sittka A, Vogel J. A glimpse at the evolution of virulence control. Cell. Host. Microbe. 4, 310-312 (2008).
27. Fleer A, Timmerman CP, Besnier JM et al. Surface proteins of coagulase-negative staphylococci: their role in adherence to biomaterials and in opsonization. J. Biomater. Appl. 5, 154-165 (1990).
28. Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 237(4822), 1588-1595 (1987). (Pubitemid 17134883)
29. Arciola CR, Radin L, Alvergna P et al. Heparin surface treatment of poly(methylmethacrylate) alters adhesion of a Staphylococcus aureus strain: utility of bacterial fatty acid analysis. Biomaterials 14, 1161-1164 (1993). (Pubitemid 24061574)
30. Arciola CR, Caramazza R, Pizzoferrato A. In vitro adhesion of Staphylococcus epidermidis on heparin-surface-modified intraocular lenses. J. Cataract Refract. Surg. 20, 158-161 (1994). (Pubitemid 24100169)
31. Patti JM, Allen BL, McGavin MJ et al. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48, 585-617 (1994).
32. Speziale P, Pietrocola G, Rindi S et al. Structural and functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the host. Future Microbiol. 4, 1337-1352 (2009).
33. Chavakis T, Wiechmann K, Preissner KT et al. Staphylococcus aureus interactions with the endothelium: the role of bacterial secretable expanded repertoire adhesive molecules (SERAM) in disturbing host defense systems. Thromb. Haemost. 94, 278-285 (2005). (Pubitemid 41122481)
34. Suree N, Liew CK, Villareal VA et al. The structure of the Staphylococcus aureus sortase-substrate complex reveals how the universally conserved LPXTG sorting signal is recognized. J. Biol. Chem. 284, 24465-24477 (2009).
35. Montanaro L, Arciola CR, Borsetti E et al. A polymerase chain reaction (PCR) method for the identification of collagen adhesin gene (cna) in Staphylococcus-induced prosthesis infections. New Microbiol. 21, 359-363 (1998). (Pubitemid 128534850)
36. Montanaro L, Arciola CR, Baldassarri L et al. Presence and expression of collagen adhesin gene (cna) and slime production in Staphylococcus aureus strains from orthopaedic prosthesis infections. Biomaterials 20, 1945-1949 (1999). (Pubitemid 29421712)
37. Montanaro L, Arciola CR, Borsetti E et al. Detection of fibronectin-binding protein genes in staphylococcal strains from peri-prosthesis infections. New Microbiol. 22, 331-336 (1999). (Pubitemid 129572121)
38. Arciola CR, Campoccia D, Gamberini S et al. Presence of fibrinogen-binding adhesin gene in Staphylococcus epidermidis isolates from central venous catheters-associated and orthopaedic implant-associated infections. Biomaterials 25, 4825-4829 (2004). (Pubitemid 38561170)
39. Arciola CR, Campoccia D, Gamberini S et al. Prevalence of cna, fnbA and fnbB adhesin genes among Staphylococcus aureus isolates from orthopedic infections associated to different types of implant. FEMS Microbiol. Lett. 246, 81-86 (2005). (Pubitemid 40616287)
40. Peacock SJ, Day NP, Thomas MG et al. Clinical isolates of Staphylococcus aureus exhibit diversity in fnb genes and adhesion to human fibronectin. J. Infect. 41, 23-31 (2000). (Pubitemid 30654747)
41. Peacock SJ, Moore CE, Justice A et al. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect. Immun. 70, 4987-4996 (2002).
42. Montanaro L, Speziale P, Campoccia D et al. Polymorphisms of agr locus correspond to distinct genetic patterns of virulence in Staphylococcus aureus clinical isolates from orthopedic implant infections. J. Biomed. Mater. Res. A. 94, 825-832 (2010).
43. Campoccia D, Speziale P, Ravaioli S et al. The presence of both bone sialoproteinbinding protein gene and collagen adhesin gene as a typical virulence trait of the major epidemic cluster in isolates from orthopedic implant infections. Biomaterials 30, 6621-6628 (2009).
44. Vancraeynest K, Hermans F, Haesebrouck F et al. Genotypic and phenotypic screening of high and low virulence Staphylococcus aureus isolates from rabbits for biofilm formation and MSCRAMMs. Vet. Microbiol. 103, 241-247 (2004). (Pubitemid 39422478)
45. Lazarevic V, Beaume M, Corvaglia A et al. Epidemiology and virulence insights from MRSA and MSSA genome analysis. Future Microbiol. 6, 513-532 (2011).
46. Arciola CR, Campoccia D, Gamberini S et al. Occurrence of ica genes for slime synthesis in a collection of Staphylococcus epidermidis strains from orthopedic prosthesis infections. Acta. Orthop. Scand. 74, 617-621 (2003). (Pubitemid 37310972)
47. Arciola CR, Baldassarri L, Montanaro L. In catheter infections by Staphylococcus epidermidis the intercellular adhesion (ica) locus is a molecular marker of the virulent slime-producing strains. J. Biomed. Mater. Res. 59, 557-562 (2002). (Pubitemid 34037500)
48. Ammendolia MG, Di Rosa R, Montanaro L et al. Slime production and expression of the slime-associated antigen by staphylococcal clinical isolates. J. Clin. Microbiol. 37, 3235-3238 (1999). (Pubitemid 29455212)
49. McKenney D, Pouliot KL, Wang Y, et al. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science 284, 1523-1527. (1999).
50. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 284, 1318-1322 (1999). (Pubitemid 29289651)
51. Mack D, Becker P, Chatterjee I et al. Mechanisms of biofilm formation in Staphylococcus epidermidis and Staphylococcus aureus: functional molecules, regulatory circuits, and adaptive responses. Int. J. Med. Microbiol. 294, 203-212 (2004). (Pubitemid 39281051)
52. Legeay G, Poncin-Epaillard F, Arciola CR. New surfaces with hydrophilic/hydrophobic characteristics in relation to (no)bioadhesion. Int. J. Artif. Organs. 29, 453-461 (2006).
53. Heilmann C, Hussain M, Peters G et al. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol. Microbiol. 24, 1013-1024 (1997). (Pubitemid 27286153)
54. Foster SJ. Molecular characterization and functional analysis of the major autolysin of Staphylococcus aureus 8325/4. J. Bacteriol. 177, 5723-5725 (1995). (Pubitemid 26028889)
55. Heilmann C, Schweitzer O, Gerke C et al. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol. Microbiol. 20, 1083-1091 (1996). (Pubitemid 26198280)
56. Gerke C, Kraft A, Sussmuth R et al. Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. J. Biol. Chem. 273, 18586-18593 (1998). (Pubitemid 28334789)
57. Cramton, SE, Gerke C, Schnell NF et al. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect. Immun. 67, 5427-5433 (1999). (Pubitemid 29455321)
58. Arciola CR, Baldassarri L, Montanaro L. Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J. Clin. Microbiol. 39, 2151-2156 (2001). (Pubitemid 32531474)
59. Mack D, Rohde H, Harris LG et al. Biofilm formation in medical device-related infection. Int. J. Artif. Organs 9, 343-359 (2006).
60. Rohde H, Knobloch JK, Horstkotte MA et al. Correlation of biofilm expression types of Staphylococcus epidermidis with polysaccharide intercellular adhesin synthesis: evidence for involvement of icaADBC genotype-independent factors. Med. Microbiol. Immunol. 190, 105-112 (2001). (Pubitemid 33141331)
61. Knobloch JK, Bartscht K, Sabottke A et al. Biofilm formation by Staphylococcus epidermidis depend on functional RsbU, an activator of the sigB operon: Differential activation mechanisms due to ethanol and salt stress. J. Bacteriol. 183, 2624-2633 (2001). (Pubitemid 32249772)
62. Bertuccini L, Ammendolia MG et al. Effect of iron limitation on biofilm production by Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 20, 343-345 (2001). (Pubitemid 33022731)
63. Cramton SE, Ulrich M, Gtz F et al. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect. Immun. 69, 4079-4085 (2002). (Pubitemid 32493332)
64. Novick RP, Muir TW. Virulence gene regulation by peptides in staphylococci and other gram-positive bacteria. Curr. Opin. Microbiol. 2, 40-45 (1999). (Pubitemid 29130213)
65. Costerton JW, Montanaro L, Arciola CR. Bacterial communications in implant infections: a target for an intelligence war. Int. J. Artif. Organs 30, 757-763 (2007). (Pubitemid 350081636)
66. Novick RP. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48, 1429-1449 (2003). (Pubitemid 36751052)
67. O'Gara JP. ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol. Lett. 270, 179-188 (2007).
68. Beenken KE, Dunman PM, McAleese F et al. Global gene expression in Staphylococcus aureus biofilms. J. Bacteriol. 186, 4665-4684. (2004). (Pubitemid 38891030)
69. Korem M, Gov Y, Kiran MD et al. Transcriptional profiling of RNA III activating protein, a master regulator of staphylococcal virulence. Infect. Immun. 73, 6220-6228 (2005). (Pubitemid 41368783)
70. Latasa C, Solano C, Penads JR et al. Biofilm-associated proteins. C. R. Biol. 329, 849-857 (2006). (Pubitemid 44597156)
71. Lasa I, Penadés JR. Bap. a family of surface proteins involved in biofilm formation. Res. Microbiol. 157, 99-107 (2006). (Pubitemid 43243686)
72. Whitchurch CB, Tolker-Nielsen T, Ragas PC et al. Extracellular DNA required for bacterial biofilm formation. Science 295 (5559), 1487 (2002). (Pubitemid 34173996)
73. Mann EE, Rice KC, Boles BR et al. Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLoS ONE 4, e5822 (2009).
74. Qin Z, Ou Y, Yang L, Zhu Y et al. Role of autolysin-mediated DNA release in biofilm formation of Staphylococcus epidermidis. Microbiol. 153, 2083-2092 (2007). (Pubitemid 47074063)
75. Rice, KC, Mann EE, Endres JL et al. The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc. Natl Acad. Sci. USA 104, 8113-8118 (2007). (Pubitemid 47185884)
76. Ranjit DK, Endres JL, Bayles KW. Staphylococcus aureus CidA and LrgA proteins exhibit holin-like properties. J. Bacteriol. 193, 2468-2476 (2011).
77. Wu J, Xi C. Evaluation of different methods for extracting extracellular DNA from the biofilm matrix. Appl. Environ. Microbiol. 75(16), 5390-5395 (2009).
78. Molin S, Tolker-Nielsen T. Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr. Opin. Biotechnol. 14(3), 255-61 (2003). (Pubitemid 36782653)
79. Arciola CR. Host defense against implant infection: the ambivalent role of phagocytosis. Int. J. Artif. Organs. 33, 565-567 (2010).
80. Thurlow LR, Hanke ML, Fritz T et al. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J. Immunol. 186, 6585-6596 (2011).
81. Darouiche RO. Treatment of infections associated with surgical implants. N. Engl. J. Med. 350, 1422-1429 (2004). (Pubitemid 38419996)
82. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 358, 135-138 (2001). (Pubitemid 32709857)
83. Toms AD, Davidson D, Masri BA et al. The management of peri-prosthetic infection in total joint arthroplasty. J. Bone Joint Surg. Br. 88, 149-155 (2006). (Pubitemid 43279921)
84. Arciola CR, Alvi FI, An YH et al. Implant infection and infection resistant materials: a mini review. Int. J. Artif. Organs. 28, 1119-1125 (2005). (Pubitemid 43085404)
85. Williams JF, Worley SD. Infection-resistant nonleachable materials for urologic devices. J. Endourol. 14, 395-400 (2000). (Pubitemid 30622509)
86. von Eiff C, Kohnen W, Becker K et al. Modern strategies in the prevention of implant-associated infections. Int. J. Artif. Organs 28, 11469-11565 (2005).
87. Langlais F, Belot N, Ropars M et al. Antibiotic cements in articular prostheses: current orthopaedic concepts. Int. J. Antimicrob. Agents 28, 84-89 (2006). (Pubitemid 44108604)
88. Dunne N, Hill J, McAfee P et al. In vitro study of the efficacy of acrylic bone cement loaded with supplementary amounts of gentamicin: effect on mechanical properties, antibiotic release, and biofilm formation. Acta Orthop. 78, 774-785 (2007). (Pubitemid 351185598)
89. Arciola CR, Maltarello MC, Cenni E et al. Disposable contact lenses and bacterial adhesion. In vitro comparison between ionic/ high-water-content and non-ionic/low-water content lenses. Biomaterials 16, 685-690 (1995).
90. Arciola CR, Montanaro L, Caramazza R et al. Inhibition of bacterial adherence to a high-water-content polymer by a watersoluble, nonsteroidal, anti-inflammatory drug. J. Biomed. Mater. Res. 42, 1-5 (1998). (Pubitemid 28412990)
91. Singh P, Cameotra SS. Potential applications of microbial surfactants in biomedical sciences. Trends Biotechnol. 22, 142-146 (2004). (Pubitemid 38230393)
92. Levy ML, Luu T, Meltzer HS et al. Bacterial adhesion to surfactant-modified silicone surfaces. Neurosurgery 54, 488-490 (2004).
93. Arciola CR, Montanaro L, Giordano M et al. Hydroxyapatite-coated orthopaedic screws as infection resistant materials: in vitro study. Biomaterials 20, 323-327 (1999). (Pubitemid 29054694)
94. Di Martino A, Sittinger M, Risbud MV. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 26, 5983-5990 (2005). (Pubitemid 40805604)
95. Arciola CR, Bustanji Y, Conti M et al. Staphylococcus epidermidis-fibronectin binding and its inhibition by heparin. Biomaterials 24, 3013-3019 (2003). (Pubitemid 36944933)
96. Bustanji Y, Arciola CR, Conti M et al. Dynamics of the interaction between a fibronectin molecule and a living bacterium under mechanical force. Proc. Natl Acad. Sci. USA 100, 13292-13297 (2003). (Pubitemid 37444735)
97. Ohko Y, Utsumi Y, Niwa C et al. Selfsterilizing and self-cleaning of silicone catheters coated with TiO(2) photocatalyst thin films: a preclinical work. J. Biomed. Mater. Res. 58, 97-101 (2001). (Pubitemid 32150707)
98. Petrini, P, Arciola CR, Pezzali I et al. Antibacterial activity of zinc modified titanium oxide surface. Int. J. Artif. Organs 29, 434-442 (2006).
99. Wu Y, Yu J, Liu HM et al. One-dimensional TiO2 nanomaterials: preparation and catalytic applications. J. Nanosci. Nanotechnol. 10, 6707-6719 (2010).
100. Monteiro DR, Gorup LF, Takamiya AS et al. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int. J. Antimicrob. Agents 34, 103-110 (2009).
101. Codita I, Caplan DM, Dragulescu EC et al. Antimicrobial activity of copper and silver nanofilms on nosocomial bacterial species. Roum. Arch. Microbiol. Immunol. 69, 204-212 (2010).
102. Zhao L, Wang H, Huo K et al. Antibacterial nano-structured titania coating incorporated with silver nanoparticles. Biomaterials 32, 5706-5716 (2011).
103. Nablo BJ, Rothrock AR, Schoenfisch MH. Nitric oxide releasing sol-gels as antibacterial coatings for orthopedic implants. Biomaterials 26, 917-924 (2005). (Pubitemid 39194963)
104. Jori G. Photodynamic therapy of microbial infections: state of the art and perspectives. J. Environ. Pathol. Toxicol. Oncol. 25, 505-519 (2006). (Pubitemid 43341261)
105. Sharma M, Visai L, Bragheri F et al. Toluidine blue-mediated photodynamic effects on staphylococcal biofilms. Antimicrob. Agents Chemother. 52, 299-305 (2008).
106. Di Poto A, Sbarra MS, Provenza G et al. The effect of photodynamic treatment combined with antibiotic action or host defence mechanisms on Staphylococcus aureus biofilms. Biomaterials 30, 3158-3166 (2009).
107. Sbarra MS, Arciola CR, Di Poto A et al. The photodynamic effect of tetra-substituted N-methyl-pyridyl-porphine combined with the action of vancomycin or host defense mechanisms disrupts Staphylococcus epidermidis biofilms. Int. J. Artif. Organs. 32, 574-583 (2009).
108. Saino E, Sbarra MS, Arciola CR et al. Photodynamic action of Tri-meso (N-methyl-pyridyl), meso(N-tetradecylpyridyl) porphine on Staphylococcus epidermidis biofilms grown on Ti6Al4V alloy. Int. J. Artif. Organs. 33, 636-645 (2010).
109. Colton MB, Ehrlich E. Bactericidal effect obtained by addition of antibiotics to dental cements and direct filling resins. J. Am. Dent. Assoc. 47, 524-531 (1953).
110. Campoccia D, Montanaro L, Speziale P et al. Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials 31, 6363-6377 (2010).
111. Dunne NJ, Hill J, McAfee P et al. Incorporation of large amounts of gentamicin sulphate into acrylic bone cement: effect on handling and mechanical properties, antibiotic release, and biofilm formation. Proc. Inst. Mech. Eng. H. 222, 355-365 (2008).
112. Nilsson IM, Patti JM, Bremell T et al. Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus mediated septic death. J. Clin. Invest. 101, 2640-2649 (1998). (Pubitemid 28294572)
113. Josefsson E, Hartford O, O'Brien L et al. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J. Infect. Dis. 184, 1572-1580 (2001). (Pubitemid 33139743)
114. Shkreta L, Talbot BG, Diarra MS et al. Immune responses to a DNA/protein vaccination strategy against Staphylococcus aureus induced mastitis in dairy cows. Vaccine 23, 114-126 (2004). (Pubitemid 39446366)
115. Maira-Litran T, Kropec A, Goldmann D et al. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide. Vaccine 22, 872-879 (2004). (Pubitemid 38177388)
116. Tang D, Devit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152-154 (1992).
117. Coban C, Koyama S, Takeshita F et al. Molecular and cellular mechanisms of DNA vaccines. Hum. Vaccin. 4, 453-456 (2008).
118. Arciola CR, Speziale P, Montanaro L. Perspectives on DNA vaccines. Targeting staphylococcal adhesins to prevent implant infections. Int. J. Artif. Organs. 32, 635-641 (2009).
119. Arciola CR. New concepts and new weapons in implant infections. Int. J. Artif. Organs. 32, 533-536 (2009).
120. Costerton WJ, Montanaro L, Balaban N et al. Prospecting gene therapy of implant infections. Int. J. Artif. Organs. 32, 689-695 (2009).
121. Good L, Awasthi SK, Dryselius R et al. Bactericidal antisense effects of peptide-PNA conjugates. Nat. Biotechnol. 19, 360-364 (2001). (Pubitemid 32275346)
122. Ray A, Nordén B. Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future. FASEB J. 14, 1041-1060 (2000). (Pubitemid 30350386)
123. Lundin KE, Good L, Strmberg R et al. Biological activity and biotechnological aspects of peptide nucleic acid. Adv. Genet. 56, 1-51 (2006). (Pubitemid 44218735)
124. Nekhotiaeva N, Awasthi SK, Nielsen PE et al. Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids. Mol. Ther. 10, 652-659 (2004). (Pubitemid 39272854)
125. Kurupati P, Tan KS, Kumarasinghe G. et al. Inhibition of gene expression and growth by antisense peptide nucleic acids in a multiresistant b-lactamase-producing Klebsiella pneumoniae strain. Antimicrob. Agents Chemother. 51, 805-811 (2007). (Pubitemid 46355259)
126. Tan XX, Actor JK, Chen Y. Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection. Antimicrob. Agents Chemother. 49, 3203-3207 (2005). (Pubitemid 41060562)
127. Montanaro L, Campoccia D, Arciola CR. Advancements in molecular epidemiology of implant infections and future perspectives. Biomaterials 28, 5155-5168 (2007). (Pubitemid 47488497)
128. Zong Y, Xu Y, Liang X et al. A Collagen Hug' model for Staphylococcus aureus CNA binding to collagen. EMBO J. 24, 4224-4236 (2005). Erratum in: EMBO J. 25, 921 (2006). (Pubitemid 41828898)
129. Patti JM, Bremell T, Krajewska-Pietrasik D et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect. Immun. 62, 152-161 (1994). (Pubitemid 24011953)
130. Mascari LM, Ross JM. Quantification of staphylococcal-collagen binding interactions in whole blood by use of a confocal microscopy shear-adhesion assay. J. Infect. Dis. 188, 98-107 (2003). (Pubitemid 36829748)
131. Patti JM, Boles JO, Hook M. Identification and biochemical characterization of the ligand binding domain of the collagen adhesin from Staphylococcus aureus. Biochem. 32, 11428-11435 (1993). (Pubitemid 23332056)
132. Elasri MO, Thomas JR, Skinner RA et al. Staphylococcus aureus collagen adhesin contributes to the pathogenesis of osteomyelitis. Bone 30, 275-280 (2002). (Pubitemid 34044328)
133. Rhem MN, Lech EM, Patti JM et al. The collagen-binding adhesin is a virulence factor in Staphylococcus aureus keratitis. Infect. Imm. 68, 3776-3779 (2000). (Pubitemid 30340493)
134. Fitzgerald JR, Loughman A, Keane F et al. Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgRIIa receptor. Mol. Microbiol. 59, 212-230 (2006).
135. Fowler T, Wann ER, Joh D et al. Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell b1 integrins. Eur. J. Cell. Biol. 79, 672-679 (2000).
136. Piroth L, Que YA, Widmer E et al. The fibrinogen-and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis. Infect. Imm. 76, 3824-3831 (2008).
137. Heying R, van de Gevel J, Que YA et al. Contribution of (sub)domains of Staphylococcus aureus fibronectin-binding protein to the proinflammatory and procoagulant response of human vascular endothelial cells. Thromb. Haemost. 101, 495-504 (2009).
138. O'Neill E, Pozzi C, Houston P et al. A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J. Bacteriol. 190, 3835-3850 (2008). (Pubitemid 351732862)
139. Que YA, Haefliger JA, Piroth L et al. Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J. Exp. Med. 201, 1627-1635 (2005). (Pubitemid 40721006)
140. Pishchany G, McCoy AL, Torres VJ et al. Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe 8, 544-550 (2010).
141. Clarke SR, Foster SJ. IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin. Infect. Immun. 76, 1518-1526 (2008). (Pubitemid 351561995)
142. Corrigan RM, Miajlovic H, Foster TJ. Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC Microbiol. 9, 22-32 (2009).
143. Reniere ML, Skaar EP. Staphylococcus aureus haem oxygenases are differentially regulated by iron and haem. Mol. Microbiol. 69, 1304-1315 (2008).
144. Cheng AG, Kim HK, Burts ML et al. Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J. 23, 3393-3404 (2009).
145. Torres VJ, Pishchany G, Humayun M et al. Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. J. Bacteriol. 188, 8421-8429 (2006). (Pubitemid 44894042)
146. Clarke SR, Brummell KJ, Horsburgh MJ et al. Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J. Infect. Dis. 193, 1098-1108 (2006).
147. Bragado R, Lpez de Castro JA, Jurez C et al. The effect of the chemical modification in human Fc g fragment on protein A and Fc receptor binding. Immunol. Lett. 5, 239-245 (1982). (Pubitemid 13141209)
148. Atkins KL, Burman JD, Chamberlain ES et al. S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation. Mol. Immunol. 45, 1600-1611 (2008). (Pubitemid 351227405)
149. Bekeredjian-Ding I, Inamura S, Giese T et al. Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands. J. Immunol. 178, 2803-2812 (2007). (Pubitemid 46333158)
150. Nguyen T, Ghebrehiwet B, Peerschke EI. Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets. Infect. Imm. 68, 2061-2068 (2000). (Pubitemid 30164837)
151. Gmez MI, Lee A, Reddy B et al. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat. Med. 10, 842-848 (2004). (Pubitemid 39070858)
152. Gmez MI, Seaghdha MO, Prince AS. Staphylococcus aureus protein A activates TACE through EGFR-dependent signaling. EMBO J. 26, 701-709 (2007).
153. Martin FJ, Gomez MI, Wetzel DM et al. Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J. Clin. Invest. 119, 1931-1939 (2009).
154. Merino N, Toledo-Arana A, Vergara-Irigaray M et al. Protein A-mediated multicellular behavior in Staphylococcus aureus. J. Bacteriol. 191, 832-843 (2009).
155. Siboo IR, Chambers HF, Sullam PM. Role of SraP, a serine-rich surface protein of Staphylococcus aureus, in binding to human platelets. Infect. Imm. 73, 2273-2280 (2005). (Pubitemid 40470828)
156. Loughman A, Fitzgerald JR, Brennan MP et al. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol. Microbiol. 57, 804-818 (2005). (Pubitemid 41025961)
157. Hair PS, Echague CG, Sholl AM et al. Clumping factor A interaction with
158. Higgins J, Loughman A, van Kessel KP et al. Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes. FEMS Microbiol. Lett. 258, 290-296 (2006).
159. Josefsson E, Hartford O, O'Brien L et al. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J. Infect. Dis. 184, 1572-1580 (2001). (Pubitemid 33139743)
160. Vernachio J, Bayer AS, Le T et al. Anticlumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis. Antimicrob. Agents Chemother. 47, 3400-3406 (2003). (Pubitemid 37345696)
161. Entenza JM, Moreillon P, Senn MM et al. Role of sB in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis. Infect. Imm. 73, 990-998 (2005). (Pubitemid 40165759)
162. Miajlovic H, Loughman A, Brennan M et al. Both complement-and fibrinogen-dependent mechanisms contribute to platelet aggregation mediated by Staphylococcus aureus clumping factor B. Infect. Imm. 75, 3335-3343 (2007). (Pubitemid 47040934)
163. O'Brien LM, Walsh EJ, Massey RC et al. Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cell. Microbiol. 4, 759-770 (2002). (Pubitemid 35378715)
164. Haim M, Trost A, Maier CJ et al. Cytokeratin 8 interacts with clumping factor B: a new possible virulence factor target. Microbiology 156, 3710-3721 (2010).
165. Corrigan RM, Miajlovic H, Foster TJ. Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC Microbiol. 9, 22-32 (2009).
166. Walsh EJ, O'Brien LM, Liang X et al. Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10. J. Biol. Chem. 279, 50691-50699 (2004). (Pubitemid 40017806)
167. Barbu EM, Ganesh VK, Gurusiddappa S et al. b-Neurexin is a ligand for the Staphylococcus aureus MSCRAMM SdrC. PLoS Pathog. 6, e1000726 (2010).
168. Sabat A, Melles DC, Martirosian G, Grundmann H et al. Distribution of the serine-aspartate repeat protein-encoding sdr genes among nasal-carriage and invasive Staphylococcus aureus strains. J. Clin. Microbiol. 44, 1135-1138 (2006).
169. Sitkiewicz I, Babiak I, Hryniewicz W. Characterization of transcription within sdr region of Staphylococcus aureus. Antonie Van Leeuwenhoek 99, 409-416 (2011).
170. O'Brien L, Kerrigan SW, Kaw G et al. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol. Microbiol. 44, 1033-1044 (2002). (Pubitemid 34535538)
171. Tristan A, Ying L, Bes M et al. Use of multiplex PCR to identify Staphylococcus aureus adhesins involved in human hematogenous infections. J. Clin. Microbiol. 41, 4465-4467 (2003). (Pubitemid 37099734)
172. Persson L, Johansson C, Rydén C. Antibodies to Staphylococcus aureus bone sialoproteinbinding protein indicate infectious osteomyelitis. Clin. Vaccine Immunol. 16, 949-952 (2009).
173. Vazquez V, Liang X, Horndahl JK et al. Fibrinogen is a ligand for the S. aureus MSCRAMM Bbp (Bone sialoprotein-binding protein. J. Biol. Chem. 286(34), 29797-29805 (2011).